BREAKING NEWS: Fewer Americans Filed for Jobless Benefits in Last Month

Search
The FTC, backed by the Justice Department, is appealing a ruling that rejected its suit against Solvay Pharmaceuticals Inc., now owned by Abbott Labs, and three generic-drug makers over Androgel, a treatment for low testosterone in men.

Photographer: Daniel Acker/Bloomberg

The FTC, backed by the Justice Department, is appealing a ruling that rejected its suit against Solvay Pharmaceuticals Inc., now owned by Abbott Labs, and three generic-drug makers over Androgel, a treatment for low testosterone in men.
December 07, 2012
Article
Generic Drug Accords Face Review by U.S. Supreme Court
« Back to Home